Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Healthcare Services (HCSG) over the last 16 years, with FY2024 value amounting to $56.8 million.

  • Healthcare Services' Cash & Equivalents rose 35975.97% to $124.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.4 million, marking a year-over-year increase of 35975.97%. This contributed to the annual value of $56.8 million for FY2024, which is 450.21% up from last year.
  • Per Healthcare Services' latest filing, its Cash & Equivalents stood at $56.8 million for FY2024, which was up 450.21% from $54.3 million recorded in FY2023.
  • Over the past 5 years, Healthcare Services' Cash & Equivalents peaked at $139.3 million during FY2020, and registered a low of $26.3 million during FY2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $56.8 million (2024), whereas its average is $69.5 million.
  • Per our database at Business Quant, Healthcare Services' Cash & Equivalents soared by 40982.47% in 2020 and then crashed by 6287.96% in 2022.
  • Annual analysis of 5 years shows Healthcare Services' Cash & Equivalents stood at $139.3 million in 2020, then plummeted by 49.19% to $70.8 million in 2021, then tumbled by 62.88% to $26.3 million in 2022, then skyrocketed by 106.74% to $54.3 million in 2023, then grew by 4.5% to $56.8 million in 2024.
  • Its Cash & Equivalents was $56.8 million in FY2024, compared to $54.3 million in FY2023 and $26.3 million in FY2022.